SYRS - Syros Pharmaceuticals' (SYRS) CEO Nancy Simonian on Q3 2019 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS)
Q3 2019 Earnings Conference Call
November 12, 2019 8:30 AM ET
Company Participants
Naomi Aoki – Vice President-Corporate Communications and Investor Relations
Nancy Simonian – Chief Executive Officer
David Roth – Chief Medical Officer
Joe Ferra – Chief Financial Officer
Eric Olson – Chief Scientific Officer
Conference Call Participants
Kenneth Atkins – Cowen
Ted Tenthoff – Piper Jaffray
Jason Butler – JMP Securities
Mark Breidenbach – Oppenheimer
Zegbeh Jallah – Roth Capital
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Q3 2019 Syros Pharmaceuticals, Inc. Earnings Conference Call.